Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Clinical Hospital Center Rijeka

Source: Site record.

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

(KBC Rijeka) is a leading tertiary-care university hospital and clinical research institution in Croatia, affiliated with the University of Rijeka Faculty of Medicine. The center serves as a major referral hub for western Croatia and supports a broad spectrum of clinical trials across therapeutic areas including oncology, cardiology, neurology, nephrology, infectious diseases, gastroenterology, endocrinology, pulmonology, pediatrics, and surgery. The institution combines advanced inpatient and outpatient infrastructure with multidisciplinary specialist clinics, modern diagnostic imaging, intensive care capabilities, transplantation programs, and laboratory medicine services, enabling participation in complex Phase II–IV clinical studies. KBC Rijeka has strong academic integration, experienced principal investigators, and access to diverse patient populations through its regional referral network. The hospital is also involved in investigator-initiated research, international…

Source: Trial-derived.
124Total Trials
Source: Trial-derived.
23Recruiting Trials
Source: Trial-derived.
57Active Trials
Source: Trial-derived.
54Completed Trials
Source: Trial-derived.
164Unique Conditions
Source: Trial-derived.
94Unique Sponsors

Conditions

Source: Trial-derived. Obesity (6)Source: Trial-derived. Diabetes Mellitus, Type 2 (5)Source: Trial-derived. Overweight (4)Source: Trial-derived. Ulcerative Colitis (UC) (4)Source: Trial-derived. Breast Cancer (3)Source: Trial-derived. Heart Failure (3)Source: Trial-derived. Psoriatic Arthritis (3)Source: Trial-derived. Schizophrenia (3)

Sponsors

Source: Trial-derived. University of Rijeka (17)Source: Trial-derived. Clinical Hospital Center Rijeka (16)Source: Trial-derived. AbbVie (15)Source: Trial-derived. Novo Nordisk A/S (13)Source: Trial-derived. Takeda (6)Source: Trial-derived. University Hospital Rijeka (5)Source: Trial-derived. Boehringer Ingelheim (3)Source: Trial-derived. Genmab (3)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits
Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. X-Ray
Source: AI-inferred. Echocardiography
Source: AI-inferred. Continuous glucose monitoring
Source: AI-inferred. Optical coherence tomography (OCT)
Source: AI-inferred. PET-CT
Source: AI-inferred. Vibration-controlled transient elastography (FibroScan)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Specimen packaging and shipment

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Liver biopsy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Bone marrow cytology
Source: AI-inferred. Measurable residual disease (MRD) assessment
Source: AI-inferred. Minimal residual disease (MRD) testing
Source: AI-inferred. Ophthalmological retinopathy examination
Source: AI-inferred. Participant mobile study app (eDiary/ePRO)
Source: AI-inferred. Protein electrophoresis and immunofixation
Source: AI-inferred. Visual acuity assessment